ArticleAmerican journal of translational research2019

Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.

Xia-Qiu Tian et al.PubMed ↗Full text ↗

No numbers read from the abstract.